May is Mental Health Awareness Month, a time dedicated to reducing stigma, improving access to care, and advocating for mental wellness. But within this important month is another critical observance: Tardive Dyskinesia (TD) Awareness Week, recognized during the first full week of May.
Tardive Dyskinesia is a serious, often permanent neurological condition that deserves far more attention than it currently receives—especially given how common the risk has become for individuals on psychiatric medications. At Different Mental Health, we’re using this week to help patients, families, and providers recognize the signs of TD and take proactive steps to identify and treat it early.
What Is Tardive Dyskinesia?
Tardive Dyskinesia (TD) is a movement disorder that results from long-term use of antipsychotic medications, which are prescribed to treat a wide variety of mental health conditions including:
- Autism-related irritability
- And even off-label for insomnia or anxiety
These medications can be life-changing—but they are not without risks. TD can emerge after months or years of use, and even “newer” second-generation antipsychotics, while lower risk than older drugs, are not risk-free. Research suggests that 1 in 14 people on second-generation antipsychotics may develop TD.
| Symptom Area | Typical Movement Pattern | Notes |
|---|---|---|
| Face | Grimacing, tongue movements | Most common |
| Mouth | Lip smacking, jaw clenching | Often first noticed |
| Limbs | Repetitive finger/hand movements | Variable severity |
| Trunk | Rocking or twisting | Less common, more disruptive |
The Reality of Living with TD
TD is more than just “twitching” or “facial tics.” The condition can include:
- Repetitive, involuntary movements in the face, mouth, tongue, jaw, hands, feet, or torso
- Pain, muscle tension, or discomfort caused by sustained movements or postures
- Difficulty chewing, swallowing, or even breathing, which can interfere with nutrition and safety
- Increased fall risk due to abnormal gait or posture
- Difficulty with everyday tasks like eating, shaving, applying makeup, or writing
- Emotional distress, including anxiety, embarrassment, or depression
- Social withdrawal due to fear of being stared at or misunderstood
TD affects not just how people move—but how they feel, function, and participate in daily life.
TD Often Goes Undiagnosed—But It Doesn’t Have To
It’s estimated that nearly 800,000 Americans are living with Tardive Dyskinesia—yet over 60% remain undiagnosed. Among racially and ethnically diverse populations, this gap is even wider due to disparities in access to care and provider education.
One reason for underdiagnosis? Many people assume they must see a neurologist to get a diagnosis. But that’s not true.
TD Can Be Diagnosed by Mental Health Professionals
You don’t need to wait six months to see a movement disorder specialist. In fact, most individuals can be diagnosed and treated by the same mental health professionals who prescribed the medication in the first place.
Frequently Asked Questions: Tardive Dyskinesia Awareness — Why Understanding TD Matters
Tardive dyskinesia is a movement disorder characterized by involuntary, repetitive movements, most often in the face, tongue, and limbs, typically associated with long-term use of certain psychiatric medications.
TD most commonly arises after prolonged use of antipsychotic medications, especially older (first-generation) drugs. It is thought to be due to changes in dopamine receptor sensitivity.
Symptoms can include facial grimacing, tongue protrusion, lip smacking, and repetitive limb movements, which may vary in severity over time.
In some cases, TD symptoms may improve with medication changes or targeted treatments, but response varies and early recognition improves management options.
Yes. Risk is higher with longer treatment duration, higher doses, first-generation antipsychotics, and in older adults
Diagnosis is based on clinical history and observation of involuntary movement patterns, often involving neurologic or psychiatric assessment.
Awareness and regular monitoring during long-term treatment with antipsychotics can help identify early signs and prompt adjustments that may limit progression.
Support can include neurologic or psychiatric care teams, movement disorder specialists, patient advocacy groups, and educational resources from reputable health organizations.
